Eye drops aim to brighten night vision for those struggling in dim light
NCT ID NCT04638660
Summary
This Phase 3 trial tested whether Nyxol eye drops could improve vision in dim light for people with night vision problems. About 144 adults used either the drops or a placebo in both eyes at bedtime for two weeks. Researchers measured whether the treatment helped participants see better in low-light conditions compared to the dummy treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIM LIGHT VISION DISTURBANCES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Site 1
Petaluma, California, 94954, United States
-
Clinical Site 10
Palisades Park, New Jersey, 07650, United States
-
Clinical Site 11
Memphis, Tennessee, 38119, United States
-
Clinical Site 13
Pittsburg, Kansas, 66762, United States
-
Clinical Site 14
Louisville, Kentucky, 41008, United States
-
Clinical Site 18
Jacksonville, Florida, 32256, United States
-
Clinical Site 19
Ogden, Utah, 84403, United States
-
Clinical Site 2
Fargo, North Dakota, 58103, United States
-
Clinical Site 20
Edgewood, Kentucky, 41017, United States
-
Clinical Site 22
High Point, North Carolina, 27262, United States
-
Clinical Site 3
Jacksonville, Florida, 32204, United States
-
Clinical Site 4
Elizabeth City, North Carolina, 27909, United States
-
Clinical Site 5
San Antonio, Texas, 78240, United States
-
Clinical Site 6
Newport Beach, California, 92663, United States
-
Clinical Site 8
Pennington, New Jersey, 08534, United States
-
Clinical Site 9
High Point, North Carolina, 27262, United States
-
Clinical Test 15
Warwick, Rhode Island, 57108, United States
Conditions
Explore the condition pages connected to this study.